000			01666 a2200469 4500
005			20250516103011.0
264		0	_c20130422
008			201304s 0 0 eng d
022			_a1440-1797
024	7		_a10.1111/j.1440-1797.2012.01646.x _2doi
040			_aNLM _beng _cNLM
100	1		_aYap, Desmond Y H
245	0	0	_aProliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience. _h[electronic resource]
260			_bNephrology (Carlton, Vic.) _cNov 2012
300			_a676-80 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEverolimus
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aKidney _xdrug effects
650	0	4	_aLupus Nephritis _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aProtein Kinase Inhibitors _xadverse effects
650	0	4	_aRetrospective Studies
650	0	4	_aSeverity of Illness Index
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSirolimus _xadverse effects
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aTacrolimus _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aMa, Maggie K M
700	1		_aTang, Colin So
700	1		_aChan, Tak Mao
773	0		_tNephrology (Carlton, Vic.) _gvol. 17 _gno. 8 _gp. 676-80
856	4	0	_uhttps://doi.org/10.1111/j.1440-1797.2012.01646.x _zAvailable from publisher's website
999			_c21962162 _d21962162